Stratify patients in a formulaic way, so that consistency in treatment decision making can be developed, while recognizing the unique needs of each patient and clinic; academic versus clinical.
Synthesize the available data regarding treatment for both oligometastatic disease and the breast primary in the setting of metastatic disease.
Know the most supported fractionation schemes for oligometastatic disease and primary breast disease.
